The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver
Open accessAbstract
Bilirubin, a breakdown product of heme, is normally glucuronidated and excreted by the liver into bile. Failure of this system can lead to a buildup of conjugated bilirubin in the blood, resulting in jaundice. The mechanistic basis of bilirubin excretion and hyperbilirubinemia syndromes is largely understood, but that of Rotor syndrome, an autosomal recessive disorder characterized by conjugated hyperbilirubinemia, coproporphyrinuria, and near-absent hepatic uptake of anionic diagnostics, has remained enigmatic. Here, we analyzed 8 Rotor-syndrome families and found that Rotor syndrome was linked to mutations predicted to cause complete and simultaneous deficiencies of the organic anion transporting polypeptides OATP1B1 and OATP1B3. These important detoxification-limiting proteins mediate uptake and clearance of countless drugs and drug conjugates across the sinusoidal hepatocyte membrane. OATP1B1 polymorphisms have previously been linked to drug hypersensitivities. Using mice deficient in Oatp1a/1b and in the multispecific sinusoidal export pump Abcc3, we found that Abcc3 secretes bilirubin conjugates into the blood, while Oatp1a/1b transporters mediate their hepatic reuptake. Transgenic expression of human OATP1B1 or OATP1B3 restored the function of this detoxification-enhancing liver-blood shuttle in Oatp1a/1b-deficient mice. Within liver lobules, this shuttle may allow flexible transfer of bilirubin conjugates (and probably also drug conjugates) formed in upstream hepatocytes to downstream hepatocytes, thereby preventing local saturation of further detoxification processes and hepatocyte toxic injury. Thus, disruption of hepatic reuptake of bilirubin glucuronide due to coexisting OATP1B1 and OATP1B3 deficiencies explains Rotor-type hyperbilirubinemia. Moreover, OATP1B1 and OATP1B3 null mutations may confer substantial drug toxicity risks.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
Merlin—rapid analysis of dense genetic maps using sparse gene flow trees
Abecasis, G. R., Cherny, S. S., Cookson, W. O., & Cardon, L. R. (2002) · Nature Genetics · doi:10.1038/ng786 · Cited by 3,354
SLCO1B1 Variants and Statin-Induced Myopathy — A Genomewide Study
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801936 · Cited by 2,043
Hagenbuch, B., & Meier, P. J. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1168-y · Cited by 1,019
Impact of OATP transporters on pharmacokinetics
Kalliokoski, A., & Niemi, M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00430.x · Cited by 995
König, J., Cui, Y., Nies, A. T., & Keppler, D. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.278.1.g156 · Cited by 620
Paulusma, C. C., Kool, M., Bosma, P. J., Scheffer, G. L., ter Borg, F., Scheper, R. J., Tytgat, G. N., Borst, P., Baas, F., & Elferink, R. O. (1997) · Hepatology · doi:10.1002/hep.510250635 · Cited by 552
Localization and Genomic Organization of a New Hepatocellular Organic Anion Transporting Polypeptide
König, J., Cui, Y., Nies, A. T., & Keppler, D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001448200 · Cited by 522
Hepatic Uptake of Bilirubin and Its Conjugates by the Human Organic Anion Transporter SLC21A6
Cui, Y., König, J., Leier, I., Buchholz, U., & Keppler, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004968200 · Cited by 515
König, J., Rost, D., Cui, Y., & Keppler, D. (1999) · Hepatology · doi:10.1002/hep.510290404 · Cited by 504
Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family
Hagenbuch, B., & Gui, C. (2008) · Xenobiotica · doi:10.1080/00498250801986951 · Cited by 412
Kartenbeck, J., Leuschner, U., Mayer, R., & Keppler, D. (1996) · Hepatology · doi:10.1002/hep.510230519 · Cited by 398
Pharmacogenomics of human OATP transporters
König, J., Seithel, A., Gradhand, U., & Fromm, M. F. (2006) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-006-0040-y · Cited by 357
Treviño, L. R., Shimasaki, N., Yang, W., Panetta, J. C., Cheng, C., Pei, D., Chan, D., Sparreboom, A., Giacomini, K. M., Pui, C.-H., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.4156 · Cited by 349
Abe, T., Unno, M., Onogawa, T., Tokui, T., Kondo, T. N., Nakagomi, R., Adachi, H., Fujiwara, K., Okabe, M., Suzuki, T., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.24804 · Cited by 345
Rius, M., Nies, A. T., Hummel-Eisenbeiss, J., Jedlitschky, G., & Keppler, D. (2003) · Hepatology · doi:10.1053/jhep.2003.50331 · Cited by 324
Expression of the UDP-glucuronosyltransferase 1A Locus in Human Colon
Strassburg, C. P., Manns, M. P., & Tukey, R. H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.15.8719 · Cited by 277
HaploPainter: a tool for drawing pedigrees with complex haplotypes
Thiele, H., & Nurnberg, P. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bth488 · Cited by 276
Drug Bioactivation Covalent Binding to Target Proteins and Toxicity Relevance
Zhou, S., Chan, E., Duan, W., Huang, M., & Chen, Y.-Z. (2005) · Drug Metabolism Reviews · doi:10.1081/dmr-200028812 · Cited by 274
Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia.
List, A. F., Spier, C., Greer, J., Wolff, S., Hutter, J., Dorr, R., Salmon, S., Futscher, B., Baier, M., & Dalton, W. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.9.1652 · Cited by 274
van Herwaarden, A. E., Jonker, J. W., Wagenaar, E., Brinkhuis, R. F., Schellens, J. H. M., Beijnen, J. H., & Schinkel, A. H. (2003) · PubMed · Cited by 269
Self-citationvan de Steeg, E., Wagenaar, E., van der Kruijssen, C. M. M., Burggraaff, J. E. C., de Waart, D. R., Elferink, R. P. J. O., Kenworthy, K. E., & Schinkel, A. H. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42168 · Cited by 226
Self-citationPhase I trial of etoposide with cyclosporine as a modulator of multidrug resistance.
Yahanda, A. M., Alder, K. M., Fisher, G. A., Brophy, N. A., Halsey, J., Hardy, R. I., Gosland, M. P., Lum, B. L., & Sikic, B. I. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.10.1624 · Cited by 214
Strassburg, C. P. (2010) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2010.07.007 · Cited by 184
Zelcer, N., Wetering, K. V. D., Waart, R. D., Scheffer, G. L., Marschall, H.-U., Wielinga, P. R., Kuil, A., Kunne, C., Smith, A., Valk, M. V. D., et al. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.07.022 · Cited by 181
Carcinogen and Anticancer Drug Transport by Mrp2 in Vivo: Studies Using Mrp2 (Abcc2) Knockout Mice
Vlaming, M. L. H., Mohrmann, K., Wagenaar, E., de Waart, D. R., Elferink, R. P. J. O., Lagas, J. S., van Tellingen, O., Vainchtein, L. D., Rosing, H., Beijnen, J. H., et al. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.101774 · Cited by 177
Self-citationZucker, S. D., Goessling, W., & Hoppin, A. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.10852 · Cited by 144
Spivak, W., & Carey, M. C. (1985) · Biochemical Journal · doi:10.1042/bj2250787 · Cited by 137
Sanna, S., Busonero, F., Maschio, A., McArdle, P. F., Usala, G., Dei, M., Lai, S., Mulas, A., Piras, M. G., Perseu, L., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp203 · Cited by 128
van de Steeg, E., van der Kruijssen, C. M. M., Wagenaar, E., Burggraaff, J. E. C., Mesman, E. M., Kenworthy, K. E., & Schinkel, A. H. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.024315 · Cited by 125
Self-citationvan Waterschoot, R. A. B., van Herwaarden, A. E., Lagas, J. S., Sparidans, R. W., Wagenaar, E., van der Kruijssen, C. M. M., Goldstein, J. A., Zeldin, D. C., Beijnen, J. H., & Schinkel, A. H. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.043869 · Cited by 121
Self-citationCui, Y., König, J., Nies, A. T., Pfannschmidt, M., Hergt, M., Franke, W. W., Alt, W., Moll, R., & KEPPLER, D. O. R. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000065015.02412.48 · Cited by 116
Pharmacogenomics of organic anion-transporting polypeptides (OATP)
Tirona, R. G., & Kim, R. B. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00077-7 · Cited by 112
Ghibellini, G., Leslie, E. M., Pollack, G. M., & Brouwer, K. L. R. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9597-0 · Cited by 99
Morimoto, K., Oishi, T., Ueda, S., Ueda, M., Hosokawa, M., & Chiba, K. (2004) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.19.453 · Cited by 96
Lee, Y.-M. A., Cui, Y., K??nig, J., Risch, A., ger, B. J., Drings, P., Bartsch, H., KEPPLER, D. O. R., & Nies, A. T. (2004) · Pharmacogenetics · doi:10.1097/00008571-200404000-00001 · Cited by 80
Zhang, W., He, Y., Gan, Z., Fan, L., Li, Q., Wang, A., Liu, Z., Deng, S., Huang, Y., Xu, L., et al. (2007) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04798.x · Cited by 79
(2008) · doi:10.1158/1078-0432.ccr-08-1609 · Cited by 57
Takane, H., Kawamoto, K., Sasaki, T., Moriki, K., Moriki, K., Kitano, H., Higuchi, S., Otsubo, K., & Ieiri, I. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0864-x · Cited by 51
Expression and Functional Analysis of CYP2D6.24, CYP2D6.26, CYP2D6.27, and CYP2D7 Isozymes
Zhang, W.-Y., Tu, Y.-B., Haining, R. L., & Yu, A. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.023663 · Cited by 29
Rotor‐type hyperbilirubinaemia has no defect in the canalicular bilirubin export pump
Hřebíček, M., Jirásek, T., Hartmannová, H., Nosková, L., Stránecký, V., Ivánek, R., Kmoch, S., Cebecauerová, D., Vítek, L., Mikulecky, M., et al. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01446.x · Cited by 25
Self-citation9 The hereditary hyperbilirubinaemias
Nowicki, M. J., & Poley, J. R. (1998) · Baillière s Clinical Gastroenterology · doi:10.1016/s0950-3528(98)90139-7 · Cited by 24
Bilirubin Metabolism and its Disorders
Roy‐Chowdhury, J., Roy‐Chowdhury, N., & Jansen, P. L. M. (2006) · Elsevier eBooks · doi:10.1016/b978-1-4160-3258-8.50079-6 · Cited by 14
Cited by
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280
SLC Transporters as Therapeutic Targets: Emerging Opportunities
Lin, L., Yee, S. W., Kim, R. B., & Giacomini, K. M. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4626 · Cited by 835
Transporters and Drug-Drug Interactions: Important Determinants of Drug Disposition and Effects
König, J., Müller, F., & Fromm, M. F. (2013) · Pharmacological Reviews · doi:10.1124/pr.113.007518 · Cited by 575
Ramsey, L. B., Johnson, S. G., Caudle, K. E., Haidar, C. E., Voora, D., Wilke, R. A., Maxwell, W. D., McLeod, H. L., Krauss, R. M., Roden, D. M., et al. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2014.125 · Cited by 433
The SLCO (former SLC21) superfamily of transporters
Hagenbuch, B., & Stieger, B. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.10.009 · Cited by 385
Metadata
- Authors
- van de Steeg, E., Stránecký, V., Hartmannová, H., Nosková, L., Hřebíček, M., Wagenaar, E., van Esch, A., de Waart, D. R., Oude Elferink, R. P. J., Kenworthy, K. E., Sticová, E., al-Edreesi, M., Knisely, A. S., Kmoch, S., Jirsa, M., & Schinkel, A. H.
- Venue
- Journal of Clinical Investigation
- Published
- 2012-02-01
- Volume
- 122
- Issue
- 2
- Pages
- 519-528
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1983184704
- Cited by
- 384
- References
- 43
- FWCI
- 15.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.